Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0970-2019Class II

C2 CryoBalloon Controller, REF: FG-1017, with Controller Software v1.18.258 The C2 CryoBalloon Ablation...

PENTAX of America, Inc. / initiated 2018-12-03 / Terminated / root cause: manufacturing process

PENTAX of America Inc began a recall of C2 CryoBalloon Controller, REF: FG-1017, with Controller Software v1.18.258 The C2 CryoBalloon Ablation System is intended to be used as a cryosurgical tool in... on . FDA classified it as Class II and gives the reason as "The Controller does not detect overpressure in the balloon during the application of non-dosing puffs of Nitrous Oxide, which can contribute to balloon over pressurization, if the intended vent lumen of the catheter is...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0970-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
PENTAX of America, Inc.
Product
C2 CryoBalloon Controller, REF: FG-1017, with Controller Software v1.18.258 The C2 CryoBalloon Ablation System is intended to be used as a cryosurgical tool in the field of general surgery, specifically for endoscopic application and the ablation of dysplastic Barrett s Esophagus.
Product code
GEH Unit, Cryosurgical, Accessories
Reason for recall
The Controller does not detect overpressure in the balloon during the application of non-dosing puffs of Nitrous Oxide, which can contribute to balloon over pressurization, if the intended vent lumen of the catheter is significantly occluded to prevent relieving balloon pressure due to a kinked catheter condition.If a patient is exposed to higher than physiologic pressures, adverse events such as perforation or mucosal laceration may occur.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On 10/18/18, the firm, Pentax Medical, started contacting US Affected Customers by telephone to inform them of the pending action and to advise they discontinue use and quarantine affected devices. On 12/03/18, "URGENT MEDICAL DEVICE REMOVAL" letters dated 11/16/18 were mailed via USPS Certified Mail to its customers. Customer response forms and Customer Return Material Shipment Labels were mailed with the removal notices. Customers were informed that affected products should not be used and should be returned to the firm. In addition, customers were asked to ensure that all potential users in their facilities are made aware of the removal notice and the recommended actions. Customers were asked to complete and return the Field Action Response Form via: Fax to PENTAX Recall Coordinator at 201-799-4063 (alternate 201-391-4189) or Email a pdf copy to [email protected], or mail with the returned affected product to:Pentax of America Inc,,303 Convention Way Suite 1, Redwood City, CA 94063, Attention: 2018-009-R Action. . Customers with additional questions were encouraged to call 650-318-5899 (8:30 AM - 5:00 PM, Monday - Friday, PST).
Quantity in commerce
45
Distribution
Worldwide Distribution: US (nationwide) to states of:: CA, DC, FL, LA, MA, MD, MN, NC, NJ, NY, OH, PA, SC, TN, TX, VA, WA;; and countries: Canada, Germany, and Netherlands.
Product codes and lots
All lot numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0970-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0970-2019Class IITerminatedVoluntary: Firm initiated